Progress of prognostic factors for Hodgkin lymphoma
10.3760/cma.j.cn115356-20200730-00194
- VernacularTitle:霍奇金淋巴瘤预后因素研究进展
- Author:
Yunxia TAO
;
Yuankai SHI
- From:
Journal of Leukemia & Lymphoma
2021;30(3):185-189
- CountryChina
- Language:Chinese
-
Abstract:
Hodgkin lymphoma (HL) is a type of curable tumor. The treatment strategy of HL is based on staging and risk of recurrence. With the continuous optimization of combined treatment mode, the prognosis of HL has been greatly improved. The predictive value of the prognostic models widely used in HL is lower than before. Therefore, exploring new prognostic factors and enriching existing prognostic models to provide patients with precise and individualized treatment is an important research direction for HL. This article reviews the progress of prognostic factors for HL in recent years.
